Virtu Financial’s Zevra Therapeutics ZVRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-62,740
| Closed | -$597K | – | 2330 |
|
|
2025
Q3 | $597K | Buy |
+62,740
| New | +$629K | 0.03% | 489 |
|
|
2024
Q4 | – | Sell |
-18,367
| Closed | -$127K | – | 2145 |
|
|
2024
Q3 | $127K | Buy |
+18,367
| New | +$125K | 0.01% | 870 |
|
|
2024
Q1 | – | Sell |
-26,966
| Closed | -$177K | – | 2198 |
|
|
2023
Q4 | $177K | Buy |
+26,966
| New | +$126K | 0.01% | 877 |
|
|
2023
Q3 | – | Sell |
-21,893
| Closed | -$112K | – | 1993 |
|
|
2023
Q2 | $112K | Buy |
+21,893
| New | +$118K | 0.01% | 1008 |
|
|
2022
Q3 | – | Sell |
-13,042
| Closed | -$58K | – | 2303 |
|
|
2022
Q2 | $58K | Sell |
13,042
-24,177
| -65% | -$110K | ﹤0.01% | 1085 |
|
|
2022
Q1 | $187K | Buy |
+37,219
| New | +$237K | 0.01% | 803 |
|
|
2021
Q3 | – | Sell |
-71,435
| Closed | -$916K | – | 2038 |
|
|
2021
Q2 | $916K | Buy |
71,435
+33,239
| +87% | +$357K | 0.09% | 234 |
|
|
2021
Q1 | $351K | Buy |
+38,196
| New | +$334K | 0.02% | 715 |
|
|
2019
Q4 | – | Sell |
-1,071
| Closed | -$12K | – | 1925 |
|
|
2019
Q3 | $12K | Buy |
1,071
+425
| +66% | +$7.68K | ﹤0.01% | 1335 |
|
|
2019
Q2 | $18K | Buy |
+646
| New | +$16.2K | ﹤0.01% | 1355 |
|
|
2018
Q3 | – | Sell |
-921
| Closed | -$96K | – | 2307 |
|
|
2018
Q2 | $96K | Sell |
921
-367
| -28% | -$35.8K | 0.01% | 1657 |
|
|
2018
Q1 | $163K | Buy |
+1,288
| New | +$125K | 0.01% | 1440 |
|
|
2017
Q4 | – | Sell |
-903
| Closed | -$53K | – | 3108 |
|
|
2017
Q3 | $53K | Buy |
+903
| New | +$48.1K | ﹤0.01% | 2219 |
|
Other funds holding ZVRA
WP
NCM
